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Background: While percutaneous treatments for severe aortic stenosis provide an important alternative for pts at high or extreme surgical risk, 
there are high rates of bleeding complications due to patient comorbidities and the large arterial sheath sizes used (10-13Fr for balloon aortic 
valvuloplasty [BAV], 18-24Fr for transcatheter aortic valve replacement).
Methods: We conducted a retrospective review of consecutive pts who underwent non-emergent, retrograde BAV from 1/2005 to 7/2011 at two 
high volume, US centers that use heparin (UFH) or bivalirudin (Biv) as procedural antithrombin. In-hospital, major bleeding was defined as Bleeding 
Academic Research Consortium type bleeding ≥ 3, and adjudicated by an independent CEC who were blinded to the antithrombin used.
Results: Of 428 pts, 205 (48%) had UFH and 223 (52%) had Biv. “Preclosure technique” for closure of the BAV access site was attempted in 245 
pts (57%). The mean age was 83 ± 9; 45% were male. There was a high prevalence of comorbidities and cardiovascular risk factors and the mean 
logistic Euroscore was 22.1% ± 18%.  38 pts (8.9%) had major bleeding post BAV. The figure shows the independent predictors of major bleeding.
Conclusion: In this two center review of elderly, high risk pts undergoing BAV, the use of Biv and access preclosure were independent predictors of 
reduced rates of major bleeding. History of prior BAV was predictive of increased bleeding. Female sex and chronic use of warfarin were of borderline 
significance with respect to bleeding risk.
